Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Rapidly improving ARDS differs clinically and biologically from persistent ARDS

Fig. 1Fig. 1

Biomarker Distribution in RIARDS versus Persistent ARDS. Plasma concentrations of interleukin-8 (A), interleukin-6 (B), plasma concentrations of tumor necrosis factor alpha (C), interleukin-10 (D), angiopoietin-2 (E), and intercellular adhesion molecule 1 (F) were not significantly different between patients with RIARDS and persistent ARDS and plasminogen activator inhibitor 1 (G) were significantly different between patients with RIARDS and persistent ARDS. Red line represents median value. Blue lines represent IQR

Back to article page